A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors

A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors

Specific signalling thresholds of the WNT/β-catenin pathway affect embryogenesis and tissue homeostasis in the adult, with mutations in this pathway frequently occurring in cancer. Excessive WNT/β-catenin activity inhibits murine anterior development associated with embryonic lethality and accounts...

Full description

Bibliographic Details
Main Authors:	Janson Tse, Ryan O’Keefe, Angela Rigopolous, Annalisa L. E. Carli, Jo Waaler, Stefan Krauss, Matthias Ernst, Michael Buchert
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomedicines
Subjects:	WNT/β-catenin signalling WNT inhibitors in vivo assay tankyrase inhibitor pyrvinium pamoate <i>APC</i>
Online Access:	https://www.mdpi.com/2227-9059/11/10/2719

Similar Items

Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor
by: Hwani Ryu, et al.
Published: (2021-07-01)

Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening
by: Bo Li, et al.
Published: (2020-04-01)

Cepharanthine suppresses APC-mutant colorectal cancers by down-regulating the expression of β-catenin
by: Guifeng Su, et al.
Published: (2024-02-01)

A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient βcatenin destruction
by: Mira I Pronobis, et al.
Published: (2015-09-01)

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
by: Kirsten Strømme Kierulf-Vieira, et al.
Published: (2020-06-01)

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
by: Alexander Scheiter, et al.
Published: (2022-08-01)

Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy
by: Melanie Spitzner, et al.
Published: (2021-09-01)

A CLINICAL STUDY OF THE USE OF PYRVINIUM PAMOATE WITH PIPERAZINE (VANPAR®) IN THE TREATMENT OF OXYURIASIS AND ASCARIASIS
by: M.A. Barzgar, et al.
Published: (1974-03-01)

In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against <i>Leishmania</i>
by: Estela Melcón-Fernández, et al.
Published: (2024-01-01)

The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
by: Jens Henrik Norum, et al.
Published: (2018-01-01)

FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
by: Carl T. Gustafson, et al.
Published: (2017-05-01)

“Losing the Brakes”—Suppressed Inhibitors Triggering Uncontrolled <i>Wnt</i>/<i>ß-Catenin</i> Signaling May Provide a Potential Therapeutic Target in Elderly Acute Myeloid Leukemia
by: Ghaleb Elyamany, et al.
Published: (2023-01-01)

Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
by: Xi-Feng Jin, et al.
Published: (2020-02-01)

Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase—A Potential Strategy for Suppression of the Wnt Pathway
by: Sujayita Roy, et al.
Published: (2015-12-01)

Structural Insight into TNIK Inhibition
by: Mutsuko Kukimoto-Niino, et al.
Published: (2022-10-01)

Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
by: Emma L. Gunderson, et al.
Published: (2022-02-01)

Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate – An example of breast cancer
by: Shu-Wei Huang, et al.
Published: (2022-02-01)

Oncogenic Serine 45-Deleted β-Catenin Remains Susceptible to Wnt Stimulation and APC Regulation in Human Colonocytes
by: Taybor W. Parker, et al.
Published: (2020-07-01)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
by: Young Yi, et al.
Published: (2021-09-01)

Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
by: Nives Pećina-Šlaus, et al.
Published: (2023-04-01)

Cross-Talk between p53 and Wnt Signaling in Cancer
by: Qiyun Xiao, et al.
Published: (2022-03-01)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
by: Alexander Chehrazi-Raffle, et al.
Published: (2021-02-01)

Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis
by: Pengfei Xu, et al.
Published: (2024-03-01)

Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
by: He K, et al.
Published: (2023-05-01)

The role of β-catenin in cardiac diseases
by: Beibei Ni, et al.
Published: (2023-03-01)

Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions
by: Teresa Catalano, et al.
Published: (2021-11-01)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
by: Yali Li, et al.
Published: (2022-12-01)

Effect of the anti-parasitic compounds pyrvinium pamoate and artemisinin in enzymatic and culture assays: Data on the search for new anti-echinococcal drugs
by: Shigehiro Enkai, et al.
Published: (2021-02-01)

Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
by: Yitian Li
Published: (2021-05-01)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
by: Morgan K. Penny, et al.
Published: (2023-07-01)

Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis
by: Yu-Hsuan Fu, et al.
Published: (2021-12-01)

SOX18 Promotes the Proliferation of Dermal Papilla Cells via the Wnt/β-Catenin Signaling Pathway
by: Mingliang He, et al.
Published: (2023-11-01)

The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options
by: Wibke Groenewald, et al.
Published: (2023-03-01)

Wnt/beta-catenin signaling in vertebrate eye development
by: Naoko Fujimura
Published: (2016-11-01)

Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells
by: Enver Tariq, et al.
Published: (2005-01-01)

β-catenin inhibitors in cancer therapeutics: intricacies and way forward
by: Arundhathi Dev, et al.
Published: (2023-12-01)

SHISA6 Confers Resistance to Differentiation-Promoting Wnt/β-Catenin Signaling in Mouse Spermatogenic Stem Cells
by: Moe Tokue, et al.
Published: (2017-03-01)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
by: Xuetong Shen, et al.
Published: (2023-09-01)

Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
by: Hui Cheng, et al.
Published: (2023-08-01)

Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
by: Bu Young Choi
Published: (2020-07-01)